-transparent.png){kind=logo}
Methylprednisolone in the form of its hemisuccinate ester was injected intravenously in doses of 10 mg/kg and 63.1 mg. Plasma levels of methylprednisolone and of the ester were measured and their kinetics were calculated. Results indicate dose dependency in the kinetics of both. About 10% of the dose was excreted unchanged as hemisuccinate in the urine, indicating incomplete conversion of the prodrug. When methylprednisolone (80 mg) was also taken by mouth, the relative bioavailability of the tablets was 99%. Saliva levels of methylprednisolone were low but paralleled plasma levels in the postdistribution phase. No methylprednisolone hemisuccinate was found in saliva.
Related Publications
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
February 1984,
Journal of chromatography,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
September 1993,
Journal of clinical pharmacology,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
August 2001,
Allergy,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
February 1980,
Pharmacological research communications,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
February 1981,
Journal of pharmaceutical sciences,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
January 1962,
Medicina experimentalis : International journal of experimental medicine,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
February 1995,
British journal of clinical pharmacology,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
March 1998,
American journal of ophthalmology,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
January 2014,
The journal of allergy and clinical immunology. In practice,
H Derendorf, and
H Möllmann, and
P Rohdewald, and
J Rehder, and
E W Schmidt
November 1988,
Journal of chromatography,
